Breaking News Instant updates and real-time market news.

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35

Daktronics adopts new shareholder rights agreement

Daktronics announced that its Board of Directors adopted a new shareholder rights agreement that will take effect when the current plan, adopted in 2008, expires on November 19, 2018. In connection with the adoption of the rights agreement, the Board declared a dividend of one right for each share of common stock outstanding at the close of business on November 19, 2018 and for each share of common stock issued after that date and before the rights are triggered or redeemed. The rights are designed to enable Daktronics shareholders to realize the full long-term value of their investment and to provide for fair and equal treatment of all shareholders if an unsolicited attempt is made to acquire Daktronics. Daktronics believes that the rights agreement will enable its Board to be in a better position to perform its fiduciary duties and help the Board to protect shareholders against abusive takeover tactics that may be used to gain control of the company without paying a price that is in the best interest of all shareholders. The rights agreement was not adopted in response to any known offers for Daktronics and is similar to rights agreements adopted by other companies. The rights agreement, which was adopted by the Board of Daktronics after evaluation and consultation with advisors of Daktronics, has no immediate dilutive effect and does not prevent Daktronics or its shareholders from accepting a fair offer to acquire Daktronics in a negotiated transaction. The rights will be exercisable only if a person or group acquires 20% or more of Daktronics' common stock or announces a tender offer, the consummation of which would result in ownership by a person or group of 20% or more of the common stock. Each right will initially entitle shareholders to buy one-one thousandth of one share of preferred stock per common share owned at an initial exercise price of $25.00 per right, subject to adjustment. At that time, Daktronics' shareholders (other than the acquirer, whose rights will have become void and will not be exercisable) would have the right to purchase, at a price equal to 50% of the common stock's market value, a number of shares of Daktronics' common stock equal to (a) the exercise price of $25.00 multiplied by the number of one one-thousandth of a share of preferred stock for which a right was exercisable divided by (b) 50% of the then current market value of Daktronics' common stock. Daktronics' Board of Directors may redeem the rights for $0.001 per right at any time before the rights become exercisable. Unless the rights are redeemed, exchanged or terminated earlier, they will expire on November 19, 2021. At any time after any person or group acquires beneficial ownership of 20% or more of Daktronics' common stock, the Board of Daktronics, at its option, may exchange each right (other than the rights owned by the acquirer, which will have become void), in whole or in part, for shares of Daktronics' common stock at an exchange ratio of one share of common stock per outstanding right.

  • 21

    Nov

DAKT Daktronics
$7.67

0.07 (0.92%)

01/24/18
SIDC
01/24/18
INITIATION
Target $10
SIDC
Neutral
Daktronics initiated with a Neutral at Sidoti
Sidoti started Daktronics with a Neutral rating and $10 price target.

TODAY'S FREE FLY STORIES

PJC

Piper Jaffray

$66.72

-1.525 (-2.23%)

05:55
12/17/18
12/17
05:55
12/17/18
05:55
Conference/Events
Piper Jaffray management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

SCG

Scana

$50.99

3.02 (6.30%)

, D

Dominion

$76.88

0.85 (1.12%)

05:54
12/17/18
12/17
05:54
12/17/18
05:54
Downgrade
Scana, Dominion rating change  »

Scana downgraded to…

SCG

Scana

$50.99

3.02 (6.30%)

D

Dominion

$76.88

0.85 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$22.90

-0.61 (-2.59%)

05:52
12/17/18
12/17
05:52
12/17/18
05:52
Initiation
Skechers initiated  »

Skechers initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

, ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

05:49
12/17/18
12/17
05:49
12/17/18
05:49
Recommendations
Argenx, Orchard Therapeutics analyst commentary  »

Goldman starts Argenx at…

ARGX

Argenx

$102.30

-0.94 (-0.91%)

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

05:48
12/17/18
12/17
05:48
12/17/18
05:48
Periodicals
Malaysian authorities file criminal charges against Goldman Sachs, WSJ says »

Malaysia's attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$32.78

-1 (-2.96%)

05:47
12/17/18
12/17
05:47
12/17/18
05:47
Conference/Events
Alkermes management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

LULU

Lululemon

$119.13

-1.08 (-0.90%)

05:42
12/17/18
12/17
05:42
12/17/18
05:42
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Jan

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Upgrade
Axovant Sciences rating change  »

Axovant Sciences upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPI

SPI Energy

$1.19

-0.02 (-1.65%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Hot Stocks
SPI Energy receives delinquency notice from Nasdaq »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

05:35
12/17/18
12/17
05:35
12/17/18
05:35
Hot Stocks
Bombardier to supply a further 20 FLEXITY trams to Karlsruhe »

Global mobility solution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$21.24

-2.25 (-9.58%)

05:32
12/17/18
12/17
05:32
12/17/18
05:32
Downgrade
Tenet rating change  »

Tenet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$60.45

-0.29 (-0.48%)

05:31
12/17/18
12/17
05:31
12/17/18
05:31
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Hot Stocks
Incyte, Innovent announce strategic collaboration, licensing agreement »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

CSL

Carlisle

$96.53

-1.69 (-1.72%)

05:26
12/17/18
12/17
05:26
12/17/18
05:26
Upgrade
Carlisle rating change  »

Carlisle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Hot Stocks
Roche SMA treatment risdiplam granted PRIME designation by EMA »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 18

    Mar

SMG

Scotts Miracle-Gro

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Upgrade
Scotts Miracle-Gro rating change  »

Scotts Miracle-Gro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:24
12/17/18
12/17
05:24
12/17/18
05:24
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.23

0.13 (0.99%)

05:18
12/17/18
12/17
05:18
12/17/18
05:18
Upgrade
Triumph Group rating change  »

Triumph Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$82.34

-1.35 (-1.61%)

05:16
12/17/18
12/17
05:16
12/17/18
05:16
Upgrade
LyondellBasell rating change  »

LyondellBasell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

, YPF

YPF

$14.38

0.03 (0.21%)

05:11
12/17/18
12/17
05:11
12/17/18
05:11
Recommendations
Ecopetrol, YPF, Petrobras analyst commentary  »

Ecopetrol price target…

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

YPF

YPF

$14.38

0.03 (0.21%)

PBR

Petrobras

$13.40

-0.235 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$62.29

0.96 (1.57%)

05:04
12/17/18
12/17
05:04
12/17/18
05:04
Recommendations
Alaska Air analyst commentary  »

Alaska Air called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$17.58

-0.14 (-0.79%)

04:59
12/17/18
12/17
04:59
12/17/18
04:59
Initiation
Avaya initiated  »

Avaya initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

04:57
12/17/18
12/17
04:57
12/17/18
04:57
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

04:56
12/17/18
12/17
04:56
12/17/18
04:56
Upgrade
Orchard Therapeutics rating change  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.